Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Novo Nordisk
Novo Nordisk
The Next Generation of Weight Loss Drugs is Rapidly Approaching
BioSpace
Mon, 11/20/23 - 11:32 am
weightloss
Novo Nordisk
Eli Lilly
Pfizer
AstraZeneca
Wegovy
Zepbound
Novo Nordisk offers staff free Wegovy
Beckers Hospital Review
Fri, 11/17/23 - 11:46 am
Novo Nordisk
Wegovy
employee benefits
Manufacturer Lonza says it will not fill obesity drug syringes
Reuters
Fri, 11/17/23 - 10:02 am
Lonza
drug manufacturing
obesity
Novo Nordisk
Eli Lilly
Novo Nordisk fights back at Lilly with Wegovy combo trial against Zepbound in obesity
https://bit.ly/49zNkYL
Wed, 11/15/23 - 12:04 pm
Novo Nordisk
Eli Lilly
clinical trials
CagriSema
Wegovy
Zepbound
obesity
German regulator eyes Ozempic export ban amid shortages across Europe
Reuters
Wed, 11/15/23 - 11:19 am
Novo Nordisk
Ozempic
Europe
Germany
exporting
Novo Nordisk says Wegovy can help heart disease patients—and not just because it produces weight loss
Fierce Pharma
Mon, 11/13/23 - 12:08 pm
Novo Nordisk
Wegovy
heart disease
cardiovascular disease
clinical trials
Wegovy cuts risk of heart attacks in milestone cardiovascular trial
Stat
Sun, 11/12/23 - 09:32 pm
Wegovy
Novo Nordisk
clinical trials
cardiovascular disease
Lilly’s Zepbound vs. Novo’s Wegovy: The Weight-Loss Drug Race Has Officially Started
Motley Fool
Sun, 11/12/23 - 09:21 pm
Eli Lilly
Zepbound
Novo Nordisk
Wegovy
weightloss
Novo Nordisk sets aside $6bn to boost production capacity
Pharmaphorum
Fri, 11/10/23 - 10:11 am
Novo Nordisk
diabetes
obesity
drug manufacturing
Senator floats new models to manage costs of weight loss drugs like Ozempic
Stat
Thu, 11/9/23 - 09:54 am
Novo Nordisk
Wegovy
Ozempic
weightloss
Senate
drug pricing
People Are Paying $25 for Wegovy, and It's Going to Keep Making Novo Nordisk Billions
Motley Fool
Thu, 11/9/23 - 09:53 am
Novo Nordisk
Wegovy
weightloss
Novo Nordisk to discontinue Levemir insulin in U.S. market
Reuters
Wed, 11/8/23 - 09:59 pm
Novo Nordisk
Levemir
insulin
diabetes
Novo Nordisk warns EU that new rules will push it to expand faster in US
Financial Times
Sun, 11/5/23 - 11:15 pm
Novo Nordisk
Europe
Novo, Lilly Weight-Loss Drug Juggernaut Has Nowhere to Go But Up
BioSpace
Sun, 11/5/23 - 11:12 pm
Novo Nordisk
Eli Lilly
Wegovy
Mounjaro
weightlosss
Novo Nordisk shrugs off supply issues with record sales
Pharmaphorum
Thu, 11/2/23 - 11:37 am
Novo Nordisk
Ozempic
earnings
Novo Nordisk is concluding research on Wegovy’s impact on osteoarthritis
Stat
Thu, 11/2/23 - 11:35 am
Novo Nordisk
Wegovy
osteoarthritis
Pfizer’s twice daily pill for obesity hopes to rival Wegovy and Mounjaro
Stat
Thu, 10/26/23 - 11:24 am
Pfizer
danuglipron
obesity
Wegovy
Mounjaro
Novo Nordisk
Demand for Ozempic and Wegovy Is Through the Roof. Here's Why it Can Go Even Higher.
Motley Fool
Wed, 10/25/23 - 09:51 am
Novo Nordisk
Ozempic
Wegovy
diabetes
weight loss
Belgium plans temporary ban on use of Ozempic for weight loss
Yahoo/Reuters
Tue, 10/24/23 - 09:39 am
Novo Nordisk
Ozempic
diabetes
weight loss
Belgium
drug shortages
NASH on the Cusp: An Emerging Market Opportunity
BioSpace
Mon, 10/23/23 - 09:53 am
NASH
Viking Therapeutics
Madrigal Pharmaceuticals
Terns Pharmaceuticals
Akero Therapeutics
Hepion Pharmaceuticals
Novo Nordisk
Galmed Pharmaceuticals
Pages
« first
‹ previous
…
2
3
4
5
6
7
8
9
10
…
next ›
last »